In November 2019, Mary Anthony of North Carolina filed a lawsuit against the producers of Zantac (ranitidine) to seek compensation for her stomach cancer, which she claims was caused by the drug.
Anthony used Zantac once a day starting in 1992, continuing use until she heard of the recall in late 2019. Her stomach cancer was diagnosed in 2012, and she continued to take the drug without possibly having any knowledge of its dangers. The case claims that drug manufacturers failed to warn about the potential carcinogenic effects of ranitidine since its release into the market. Her lawsuit states that these companies conducted business “with reckless disregard for human life, oppression, and malice,” and that they were “fully aware of the safety risks of Zantac, particularly the carcinogenic potential of Zantac as it transforms into NDMA within the chemical environment of the human body. Nonetheless, Defendants deliberately crafted their label, marketing and promotion to mislead consumers.”
Since ranitidine was petitioned for recall in September 2019, there have been many similar lawsuits against the companies that manufacture it. The recall petition was filed by the company Valisure, which conducts routine testing of drugs. One test in June 2019 showed excessive levels of the carcinogen N-nitrosodimethlylamine (NDMA) in Zantac samples, and further tests demonstrated that those levels could increase when ranitidine was in the body.
What Additional Types of Cancers are being Linked to using Zantac?
Zantac and similar drugs have been used (and marketed as safe) since Ranitidine was introduced to the market in the 1980s. Many individuals who suffer from heartburn, indigestion, acid reflux and similar symptoms have been treating their discomfort with the drug for years or even decades. Zantac may be tied to various types of cancers, since the formation of NDMA following the ingestion of Zantac (Ranitidine) may occur throughout different areas of the body.
Those unfortunate enough to have developed any of the following cancers due to regular and prolonged usage of Zantac or similar heartburn medications may be eligible to receive compensation:
Bladder cancer
Liver cancer
Esophageal/colorectal cancer
Kidney/renal cancer
Leukemia
Multiple Myeloma
Non-Hodgkin's Lymphoma
Pancreatic cancer
Prostate cancer
Small intestine cancer
How Can We Help?
If you or a loved one has developed one of the above cancers after using Zantac (ranitidine), make sure to contact us at Kwartler Manus. Our dedicated attorneys have experience representing clients in similar cases. By filing/joining a mass tort claim against Zantac, you may be able to get compensation for your damages and protect others from future threats. Our attorneys will be by your side to help you navigate this complex process with ease and help you win the money you deserve.
Don’t hesitate to pursue the compensation you deserve to make up for these pharmaceutical companies’ mistakes. Contact us today to schedule a free consultation and learn your rights.
